Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena

Overview of attention for article published in Kidney International Supplements, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 151)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet
patent: 2 patents

guideline: 2 clinical guideline sources

Readers on

mendeley: 66 Mendeley

So far, Altmetric has seen 1 news story.

ZORA real-world evidence demonstrates that Lokelma substantially increases cardiorenal patients’ chances of maintaining lifesaving RAASi therapy

PharmiWeb, 02 Nov 2023

Treating hyperkalaemia with Lokelma more than doubled the odds (by ~2.5 times) of patients maintaining guideline RAASi therapy…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.